Peptide record

TPDB92604

IVO-2 Anticancer Antiviral Tumor-homing Peptides modified_plain modified
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92604
IVO-2
Anticancer Antiviral Tumor-homing Peptides
Anti-infective peptides Cancer-related peptides
Peptipedia AI4AVP DRAVP 2.0 StackTHP StackTHPred TumorHoPe2.0
modified_plain
Yes
A 12-aa modified multi-activity (Anticancer, Antiviral, and Tumor-homing Peptides) peptide sequence curated from Peptipedia, AI4AVP, DRAVP 2.0, and other sources, with an available 3D structural model.
N-terminal: FITC or biotin
Sequence
SVSVGMKPSPRP
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
12 reviewed residue count
FITC or biotin Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Tumor vessel
Targeting
Oral cancer

Source & Reference

TumorHoPe2.0
TumorHoPe2
Tumor-targeting peptides and uses thereof
2013
US 8394758 B2
US 8394758 B2

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
SAS cells (an oral cancer cell line), H460 cells (a lung cancer cell line)
SCID mice (4-6 weeks of age
Phage display library
M13
doxorubicin
Additional Detail Fields 4 fields
doxorubicin
SAS cells (an oral cancer cell line), H460 cells (a lung cancer cell line)
SCID mice (4-6 weeks of age
M13